CHE  Chemed Corp.

Exchange

NYSE

Sector

Health Care

Industry

Medical/Nursing Services

Market Cap.

1.818B

Vuru Grade

60.61/100

Current Price

$106.85
+0.01 (+0.01%)

Growth Price

$89.31
Overvalued by 16.42%

Stability Price

$102.01
Fairly valued

Company Metrics

  • 20.74 P/E
  • 1.27 P/S
  • 4.20 P/B
  • 5.152 EPS
  • 20.03% Cash ROIC
  • 0.23 Cash Ratio
  • 0.84 / 0.79 % Dividend
  • 167,695.00 Avg. Vol.
  • 17.01M Shares
  • 1.818B Market Cap.

Company Description

Chemed Corporation, through its subsidiaries, provides hospice care, and repair and cleaning services in the United States. The company operates in two segments, Vitas and Roto-Rooter. The Vitas segment offers hospice services to terminally ill patients. This segment provides hospice services in the areas of routine home care, general inpatient care, continuous care, and Medicare cap. It also offe...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

A Value Investor's Dream: Chemed Corporation
Seeking Alpha - Nov 5, 2013
Chemed Corporation (NYSE:CHE) is the parent company of two subsidies: 1) Roto-Rooter and 2) VITAS. Roto-Rooter operates through 110 company-owned branches and independent contractors, and over 400 franchisees.
Chemed Corporation to Present at the 2014 Credit Suisse Healthcare Conference
Business Wire (press release) - Nov 4, 2014
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 2014 Credit Suisse Healthcare Conference on Tuesday, November 11, 2014, at approximately 11:30 a.m.
Chemed Corporation to Present at the Oppenheimer 25th Annual Healthcare ...
MarketWatch - Feb 18, 2005
CINCINNATI, Dec 03, 2014 (BUSINESS WIRE) -- Chemed Corporation CHE, -0.37% today announced that it will deliver a presentation at the Oppenheimer 25th Annual Healthcare Conference on Wednesday, December 10, 2014, at approximately 8:00 a.m.
Lawsuit on Behalf of Investors in Chemed Corporation (CHE) Announced by ...
GlobeNewswire (press release) - Sep 17, 2013
SAN DIEGO, Sept. 17, 2013 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending on behalf of certain purchasers of Chemed Corporation (CHE) common stock over alleged violations of Federal Securities Laws by ...
Chemed Corporation (CHE): Hedge Funds Are Bullish and Insiders Are ... - Insider Monkey (blog)
Chemed Corporation Announces Receipt of False Claims Action Complaint
Business Wire (press release) - May 3, 2013
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation ("Chemed") (NYSE:CHE). On May 2, 2013, the government filed a False Claims Act complaint against the Company and certain of its hospice-related subsidiaries in the Western District of Missouri, ...
Roto-Rooter Owner Destroyed as DOJ Goes After Hospice Fraud - 24/7 Wall St.
Chemed Declines Most in Five Years on Medicare Lawsuit - Bloomberg
Chemed Corporation's Board of Directors Authorizes an Additional $100 Million ...
MarketWatch (press release) - Feb 21, 2013
CINCINNATI, Feb 21, 2014 (BUSINESS WIRE) -- Chemed Corporation CHE, +0.66% announced today that the Board of Directors has formally authorized an additional $100 million for stock repurchase under Chemed's existing share repurchase program.
Chemed Corp.: Major Player in Hospice and Plumbing
Seeking Alpha (blog) - Feb 26, 2007
Chemed Corporation (NYSE:CHE), formerly Roto-Rooter, Inc. is headquartered in Cincinnati, Ohio. Publicly traded since 1971, Chemed currently operates in the healthcare field through its Vitas Healthcare Corporation subsidiary, and in the residential ...
Hedge Funds Are Dumping Chemed Corporation (CHE)
Insider Monkey (blog) - Apr 14, 2013
Chemed Corporation (NYSE:CHE) was in 8 hedge funds' portfolio at the end of the fourth quarter of 2012. CHE investors should be aware of a decrease in activity from the world's largest hedge funds in recent months.
This Metric Says You Are Smart to Sell Chemed Corporation (CHE)
Insider Monkey (blog) - Jun 14, 2013
According to our comprehensive database, Chuck Royce's Royce & Associates had the most valuable position in Chemed Corporation (NYSE:CHE), worth close to $113.8 million, comprising 0.3% of its total 13F portfolio. The second largest stake is held by ...
Chemed's CEO on the federal lawsuit and the investor who's shorting his stock
Business Courier of Cincinnati (blog) - May 17, 2013
Chemed Corp. CEO Kevin McNamara said his company isn't engaged in fraud and that a short seller who is targeting the firm is engaged in “wishful thinking.